Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives

Therapeutic agents targeting bacterial virulence factors are gaining interest as non-antibiotic alternatives for the treatment of infectious diseases. Clostridium difficile is a Gram-positive pathogen that produces two primary virulence factors, enterotoxins A and B (TcdA and TcdB), which are respon...

Full description

Bibliographic Details
Main Authors: Greg Hussack, Jamshid Tanha
Format: Article
Language:English
Published: MDPI AG 2010-05-01
Series:Toxins
Subjects:
Online Access:http://www.mdpi.com/2072-6651/2/5/998/

Similar Items